Skip to main content
PACS logo

PACS Group, Inc. (PACS) Stock: Price, Forecast & Analyst Target

PACS Group, Inc. (PACS) — MoonshotScore 90/100 (Exceptional band), calculated Oct 26, 2026. Price $48.76 (+2.35%), as of the Oct 26, 2026 trading session; market cap $7.70B. Expected results Nov 25, 2026.

Listing-status flag — 8-K Item 3.01, filed Nov 26, 2024.

Educational signal · not a buy or sell recommendation · How to read this

Market value / cash and short-term investments: 46.82× (market value Oct 26, 2026; cash Jun 30, 2026) · expected results Nov 25, 2026

$48.76 +$1.12 (+2.35%) Market Cap $7.70B

PACS Group, Inc. · PACS · NYSE · Healthcare · Medical - Care Facilities

Research dated 2026-09-13: PACS Group is a holding company built around skilled post-acute care, ancillary support, and selected senior living communities. The case rests on whether rising facility revenue can keep producing durable earnings and cash while debt remains far larger than available liquidity.

Price as of Oct 26, 2026

Key Statistics

90 of 100

MoonshotScore v2 · PACS Group (PACS)

Exceptional
Business Quality Solid (79)
Financial Safety Strained (39)
Valuation Fair (63)
Growth Durability Compounding (99)
Momentum Surging (94)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

High quality and elite growth, but a strained balance sheet; the market is already moving on it. Business Quality: Solid; Financial Safety: Strained; Valuation: Fair; Growth Durability: Compounding; Momentum: Surging.

  • quarterly revenue $1.43B (Q2 FY2026, quarter ended Jun 30, 2026)
  • EPS beat 4 of 8
  • Altman Z 2.31 · Piotroski F 7

Helping: business quality, durable growth, positive momentum

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for PACS (42 recorded, newest six shown)
RecordedScoreBand
91Exceptional
91Exceptional
91Exceptional
91Exceptional
90Exceptional
90Exceptional

The score was 90 in the stored Oct 24, 2026 snapshot and remains 90 in the current publication computed Oct 26, 2026 (0); the largest pillar moves were Financial Safety +1; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →

Price & valuation

As of
MeasureValue
Latest provided price$48.76
Change on the day+2.35%
52-week range$10.31–$49.78
Market capitalisation$7.70B
Price / earnings (trailing)28.02
Shares traded on the day1.09M
Beta (volatility vs the S&P 500)-0.08

Price & events

Weekly closing price with reported quarters marked Weekly closing price from Sep 26, 2025 to Oct 26, 2026: low $11, high $49, latest $49. 4 reported quarters marked, 2 above and 2 below the recorded estimate. 1 other dated event marked. $49 $11 high $49 Nov 19, 2025 · Earnings results · reported below the recorded estimate · close $281Feb 26, 2026 · Earnings results · reported below the recorded estimate · close $372May 11, 2026 · Earnings results · reported above the recorded estimate · close $343Aug 4, 2026 · Earnings results · reported above the recorded estimate · close $484Aug 5, 2026 · Earnings call · management outlook · no recorded estimate to compare · close $485 Sep 26, 2025 Oct 26, 2026 · $49 $14Sep 26, 2025$13Oct 10, 2025$13Oct 24, 2025$12Nov 7, 2025$28Nov 21, 2025$31Dec 5, 2025$36Dec 19, 2025$40Jan 2, 2026$39Jan 16, 2026$34Jan 30, 2026$38Feb 13, 2026$37Feb 27, 2026$35Mar 13, 2026$31Mar 27, 2026$34Apr 10, 2026$35Apr 24, 2026$34May 8, 2026$38May 22, 2026$37Jun 5, 2026$37Jun 18, 2026$44Jul 2, 2026$46Jul 17, 2026$46Jul 31, 2026$44Aug 14, 2026$43Aug 28, 2026$45Sep 11, 2026$41Sep 25, 2026$43Oct 9, 2026$48Oct 23, 2026

Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file or a dated event that is not a results report. Numbers key to the dated list. Point at or tab to any week for its close.

Events behind the price

  • · Earnings results · below the recorded estimate
  • · Earnings results · below the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings results · above the recorded estimate
  • · Earnings call · management outlook

Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.

Upcoming events

As of

  1. Next results dueProvider estimate

Management outlook

  • As we look at the back half of the year, we expect to continue to perform at a high level, and therefore, we're increasing both our full year revenue and our adjusted EBITDA guidance.

    Carey Hendrickson · Statement from

  • I would say we do expect to receive them in the second half of the year, but we've not included any of that in our guidance.

    Carey Hendrickson · Statement from

Statement dates identify the earnings call, not a deadline. Management expectations and provider estimates can change.

Read management statements

Other perspectives

Council score for PACS Group (PACS): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Growth Durability Strong
Momentum Strong
Business Quality Moderate
Financial Safety Weak
Valuation Moderate

Legends Council

6 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Griffin-style lens (simulated) Ken Griffin Neutral read
Simons-style lens (simulated) Jim Simons Neutral read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Favorable read
Moon AI lens (model) Favorable read

Read on: Oct 12, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Strong
Debt/Equity Negative
ROE Strong
Gross Margin Weak

Read on: Sep 11, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 11, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Oct 27, 2026, except a card that shows its own read date.

Watch the PACS film — every key number, told as a short cinematic story

~2 min · open the film

1 · What is it?

What is PACS Group (PACS), and what does it report?

Short answer · as of

PACS earns revenue by operating care facilities, supplying skilled professionals, and delivering ancillary services; selected communities also offer senior care, assisted living, and independent living.

Research dated 2026-09-13.

PACS earns revenue by operating care facilities, supplying skilled professionals, and delivering ancillary services; selected communities also offer senior care, assisted living, and independent living. It is therefore more than a property owner or a conventional senior-housing operator: the operating care platform is the business.

The financial statements place all disclosed revenue inside the same reportable segment. That presentation captures the combined platform but does not separate the economics of post-acute services from the senior living offerings.

Sources (as of 2026-09-13): Business description; Sector / industry (provider taxonomy); Employees; Revenue by segment

2 · Latest results

What do the latest results show for PACS Group (PACS)?

Short answer · as of

The most recent reported quarter, Q2 FY2026, carried revenue of $1.43B.

Research dated 2026-09-13.

Revenue advanced again in the latest quarter, while gross profit expanded sharply. Operating profit and net income eased from the preceding quarter, showing that the gross-profit improvement did not carry fully through the income statement.

The latest release exceeded revenue and earnings estimates. Management subsequently raised its revenue and adjusted operating-profit outlook, while saying anticipated receipts were excluded from that guidance; the outlook is constructive, but it is not an explanation for the latest margin movements.

Sources (as of 2026-09-13): Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters; Management outlook — dated call excerpts; Most recent periodic reports

Where is operating spending going?

Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.

Latest quarter · revenue
$1.43B Jun 30, 2026
Latest quarter · SG&A
$114.31M Jun 30, 2026
Latest quarter · FMP standardized operating result
$109.33M Jun 30, 2026
Where is operating spending going? — FMP standardized evidence
Period endRevenueR&DSG&AFMP standardized operating result
Jun 30, 2026$1.43BNot available$114.31M$109.33M
Mar 31, 2026$1.42BNot available$112.31M$120.03M
Dec 31, 2025$1.36BNot available$113.49M$94.69M
Sep 30, 2025$1.34BNot available$102.53M$86.27M

USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.

Did results meet expectations?

Reported earnings and revenue alongside the estimates recorded by the provider.

Latest report · revenue
$1.43B Aug 4, 2026
Latest report · revenue estimate
$1.41B Aug 4, 2026
Latest report · revenue vs estimate
Above estimate Aug 4, 2026
Latest report · EPS vs estimate
Above estimate Aug 4, 2026
Did results meet expectations? — reported evidence
Report dateRevenue · reportedRevenue · estimateEPS · reportedEPS · estimate
Aug 4, 2026$1.43B$1.41B$0.6300$0.5370
May 11, 2026$1.42B$1.36B$0.5000$0.4200
Feb 26, 2026$1.36B$1.38B$0.4300$0.4800
Nov 19, 2025$1.34B$1.11B$0.3300$0.4500

Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q2 FY2026$1.43B$76M$0.47 (diluted)
Q1 FY2026$1.42B$81M$0.50 (diluted)
Q4 FY2025$1.36B$60M$0.38 (diluted)
Q3 FY2025$1.34B$52M$0.32 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for PACS Group (PACS)?

Short answer

Cash and short-term investments were $164.45M at the Jun 30, 2026 balance-sheet date. Operating cash flow was $135.51M for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.

Research dated 2026-09-13.

PACS has delivered sustained revenue expansion, and recent quarters produced positive operating cash flow after a brief cash outflow. Earnings also recovered substantially from the weaker annual result that preceded the latest growth phase.

Leverage is the counterweight. Cash and short-term investments cover only a small portion of debt, short-term liquidity ratios sit below full coverage, and cash generation has varied markedly between quarters. A staffing disruption across this large care workforce, or weaker conversion of facility revenue into cash, would leave less financial room for error.

Sources (as of 2026-09-13): Annual revenue and net result (USD millions); Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and short-term investments over time (USD millions); Trailing twelve-month ratio set; Employees

How much cash does the business generate or use?

Quarterly operating cash flow shows cash generated or used by operations.

Latest quarter · operating cash flow
$135.51M Jun 30, 2026
Previous quarter · operating cash flow
$236.34M Mar 31, 2026
How much cash does the business generate or use? — reported evidence
Period endOperating cash flowCapital expenditure (reported)
Jun 30, 2026$135.51M−$26.53M
Mar 31, 2026$236.34M−$21.83M
Dec 31, 2025−$3.39M−$51.11M
Sep 30, 2025$204.80M−$18.01M

Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.

USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.

4 · What to check next?

What should you watch next at PACS Group (PACS)?

Short answer · as of

The next earnings report is expected on Nov 25, 2026.

Research dated 2026-09-13.

Watch whether revenue keeps advancing without another drop in operating profit or net income. Gross profit moved differently from downstream earnings in the latest quarter, so conversion through operating expenses matters more than topline growth alone.

Cash conversion deserves equal attention: operating cash flow remained positive but retreated from the prior quarter, while the cash balance fell and debt stayed substantial. The scheduled earnings release also provides a direct test of management's raised outlook and the market's expectation for continued growth.

Sources (as of 2026-09-13): Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and short-term investments over time (USD millions); Next earnings report; Analyst revenue and earnings estimates (average); Management outlook — dated call excerpts

What management is planning

Management expectations, not completed milestones or guarantees. Selected verbatim excerpts; dates follow the transcript provider.

  1. As we look at the back half of the year, we expect to continue to perform at a high level, and therefore, we're increasing both our full year revenue and our adjusted EBITDA guidance.

    Carey Hendrickson ·

  2. I would say we do expect to receive them in the second half of the year, but we've not included any of that in our guidance.

    Carey Hendrickson ·

5 · Peer comparison

How does PACS Group compare with its peers?

Short answer

PACS Group's score ranks 4th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Research dated 2026-09-13.

PACS combines skilled post-acute operations, ancillary support, and selected senior living formats inside the same platform. That mix differs from a care-facility business centered only on housing or from a service provider that supplies facilities without operating them.

Its segment reporting does not split those activities into separate businesses, so comparison with more narrowly organized operators depends on consolidated margins, cash conversion, and leverage rather than a clean segment-by-segment read.

Sources (as of 2026-09-13): Sector / industry (provider taxonomy); Business description; Revenue by segment; Trailing twelve-month ratio set; Operating cash flow by quarter (USD millions)

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
National HealthCare Corporation (NHC) Same industry, near in market value$223.70 Oct 26, 2026$3.50B98 5-pillar Oct 26, 2026
Universal Health Services, Inc. (UHS) Same industry, near in market value$185.71 Oct 26, 2026$11.0B94 5-pillar Oct 26, 2026
LifeStance Health Group, Inc. (LFST) Same industry, near in market value$13.06 Oct 26, 2026$4.99B94 5-pillar Oct 26, 2026
PACS Group (PACS) — this page$48.76$7.70B90
Chemed Corporation (CHE) Same industry, near in market value$512.90 Oct 26, 2026$6.71B87 5-pillar Oct 26, 2026
Encompass Health Corporation (EHC) Same industry, near in market value$124.10 Oct 26, 2026$12.2B87 5-pillar Oct 26, 2026
Option Care Health, Inc. (OPCH) Same industry, near in market value$31.23 Oct 26, 2026$4.68B85 5-pillar Oct 26, 2026
Fresenius Medical Care AG & Co. KGaA (FMS) Same industry, near in market value$22.75 Oct 26, 2026$12.1B83 5-pillar Oct 26, 2026
Aveanna Healthcare Holdings Inc. (AVAH) Same industry, near in market value$13.18 Oct 26, 2026$2.90B82 5-pillar Oct 26, 2026
The Ensign Group, Inc. (ENSG) Same industry, near in market value$176.92 Oct 26, 2026$10.2B76 5-pillar Oct 26, 2026
DaVita Inc. (DVA) Same industry, near in market value$184.03 Oct 26, 2026$11.8B76 5-pillar Oct 26, 2026
Solventum Corporation (SOLV) Same industry, near in market value$85.81 Oct 26, 2026$14.5B61 5-pillar Oct 26, 2026
Stifel Financial Corp. (SF) Named competitor$66.52 Oct 26, 2026$10.0B51 5-pillar Oct 26, 2026

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

Screen more Healthcare stocks

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$48.00 – $62.00
Consensus target
$56.67
Median target
$60.00

Consensus record · Captured .

Measured against a quoted price of $48.76 (as of Oct 26, 2026).

Insider activity

Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Oct 21, 2026

Transactions
59
Identified insiders
5
Purchases
0
Sales
58
Other transactions
1

Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.

Who holds the shares?

Institutional ownership reported through 13F filings.

Institutional ownership
31.8% Period end Jun 30, 2026
Previous quarter · ownership
29.8% Prior to period end Jun 30, 2026
Reporting holders
251 Period end Jun 30, 2026
Previous quarter · holders
226 Prior to period end Jun 30, 2026
Who holds the shares? — reported evidence
Holders in provider snapshotShares
Cohen & Steers, INC.8,343,381
Fmr LLC6,207,375
Blackrock, INC.4,155,408
Crewe Advisors LLC3,307,188
American Century Companies INC3,108,196

Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.

What has been published about PACS Group (PACS)?

Read these with our analysis →

What Investors Ask About PACS Group (PACS) — Healthcare

Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.

What does PACS sell beyond skilled post-acute care?

PACS also provides ancillary support and offers senior care, assisted living, and independent living in selected communities. Those services sit alongside facility operations rather than appearing as a separately disclosed revenue segment.

Sources (as of 2026-09-13): Business description; Revenue by segment; Sector / industry (provider taxonomy)

Does PACS separate post-acute care from senior living in its segment reporting?

Disclosed revenue is presented within the same reportable segment. Investors therefore see the combined economics of facility operations, care services, ancillary support, and selected senior living offerings.

Sources (as of 2026-09-13): Revenue by segment; Business description; Annual revenue and net result (USD millions)

How did the latest PACS quarter differ from the preceding quarter?

Revenue edged higher and gross profit rose sharply, but operating profit and net income declined. The release nevertheless exceeded market estimates for revenue and earnings.

Sources (as of 2026-09-13): Quarterly income statement (USD thousands); Reported versus estimated, last 8 quarters; Most recent periodic reports

Why is PACS cash generation worth watching alongside facility growth?

Operating cash flow has fluctuated materially even as revenue expanded, and the latest cash balance is modest beside total debt. Continued cash conversion is therefore important to preserving financial flexibility as the care platform grows.

Sources (as of 2026-09-13): Operating cash flow by quarter (USD millions); Cash, investments and debt; Cash and short-term investments over time (USD millions); Annual revenue and net result (USD millions); Cash against market value

What is the PACS stock price today?

The last price recorded on this page for PACS Group, Inc. (PACS) is $48.76, as of the Oct 26, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the PACS price target?

The analyst consensus price target for PACS Group, Inc. (PACS) is $56.67 (range $48.00 to $62.00, median $60.00), per FMP data captured Oct 26, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources (as of 2026-09-13): Legal name; Business description; Quarterly income statement (USD thousands); Operating cash flow by quarter (USD millions); Cash, investments and debt

Sources — records for every figure on this page (81 figures)

The 81 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.

"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.

OFFICIAL — 3 facts from SEC filings and earnings calls

OFFICIAL facts used on this page
Fact IDFactValue as shownAs ofTierSource
list.rule_noticeListing-status notice (8-K Item 3.01)8-K Item 3.01, filed Nov 26, 2024OFFICIALSEC EDGAR — Form 8-K, Item 3.01 — Item 3.01 covers both continued-listing notices and voluntary transfers between exchanges; the filing states which applies and any cure terms.
prod.outlookManagement outlook — call excerptsCarey Hendrickson (Aug 5, 2026): As we look at the back half of the year, we expect to continue to perform at a high level, and therefore, we're increasing both our full year revenue and our adjusted EBITDA guidance. Carey Hendrickson (Aug 5, 2026): I would say we do expect to receive them in the second half of the year, but we've not included any of that in our guidance.OFFICIALCompany earnings call, transcript via Financial Modeling Prep (FMP) — Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording.
id.hqSEC filing business addressSalt Lake City, UTOFFICIALSEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "90 S. 400 W, Salt Lake City, UT, 84101, US". The FMP company description names Farmington, Utah as the headquarters; this page uses the address in this row.

FMP — 71 facts from Financial Modeling Prep endpoint families

FMP facts used on this page
Fact IDFactValue as shownAs ofTierSource
earn.nextNext earnings dateNov 25, 2026FMPFinancial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it.
px.lastLatest provided price$48.76FMPFinancial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-26T22:04:46.715Z.
px.changeChange on the day+2.35%FMPFinancial Modeling Prep (FMP) · quote
px.mcapMarket capitalization$7.70BFMPFinancial Modeling Prep (FMP) quote — Provider market cap uses the share class it prices; a company with more than one class may show a larger total elsewhere. Market cap record date: 2026-10-26. Source capture time was not supplied. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares.
px.change_absChange on the day, in dollars+$1.12FMPFinancial Modeling Prep (FMP) · quote
fin.q_revenueRevenue, Q2 FY2026$1.43BFMPFinancial Modeling Prep (FMP) · income statement (quarterly)
px.range5252-week range$10.31–$49.78FMPFinancial Modeling Prep (FMP) quote
px.pePrice / earnings (trailing)28.02FMPFinancial Modeling Prep (FMP) · quote
px.volumeShares traded on the day1.09MFMPFinancial Modeling Prep (FMP) · quote
px.betaBeta-0.08FMPFinancial Modeling Prep (FMP) company profile
id.ceoChief executiveJason MurrayFMPFinancial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it.
id.founderFounder named in the filingMark Hancock — Co-Founder & Vice ChairmanFMPFinancial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it.
id.employeesEmployees47,455FMPFinancial Modeling Prep (FMP) employee count, from the company's filing
fin.annualRevenue and net result by fiscal year5 fiscal years, FY2021 through FY2025: FY2021 revenue $1.17B, net result $47.95M; FY2022 revenue $2.42B, net result $150.50M; FY2023 revenue $3.11B, net result $112.87M; FY2024 revenue $4.09B, net result $55.76M; FY2025 revenue $5.29B, net result $191.54MFMPFinancial Modeling Prep (FMP), from the company's 10-K income statements
fin.rev_mixReported revenue segmentsReportable Segment $5.29BFMPFinancial Modeling Prep (FMP) revenue segmentation, from the company's 10-K
fin.gross_marginGross margin (trailing twelve months)19.7%FMPFinancial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero.
fin.q_table.depth.2026-06-30.revenue_kRevenue — period end 2026-06-30$1.43BPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2026-06-30.sga_kSG&A — period end 2026-06-30$114.31MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2026-06-30.operating_result_kFMP standardized operating result — period end 2026-06-30$109.33MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2026-03-31.revenue_kRevenue — period end 2026-03-31$1.42BPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2026-03-31.sga_kSG&A — period end 2026-03-31$112.31MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2026-03-31.operating_result_kFMP standardized operating result — period end 2026-03-31$120.03MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2025-12-31.revenue_kRevenue — period end 2025-12-31$1.36BPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2025-12-31.sga_kSG&A — period end 2025-12-31$113.49MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2025-12-31.operating_result_kFMP standardized operating result — period end 2025-12-31$94.69MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2025-09-30.revenue_kRevenue — period end 2025-09-30$1.34BPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2025-09-30.sga_kSG&A — period end 2025-09-30$102.53MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
fin.q_table.depth.2025-09-30.operating_result_kFMP standardized operating result — period end 2025-09-30$86.27MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note
earn.history.depth.2026-08-04.revenue_actualRevenue · reported — report date 2026-08-04$1.43BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-08-04.revenue_estimatedRevenue · estimate — report date 2026-08-04$1.41BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-08-04.eps_actualEPS · reported — report date 2026-08-04$0.6300Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-08-04.eps_estimatedEPS · estimate — report date 2026-08-04$0.5370Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-05-11.revenue_actualRevenue · reported — report date 2026-05-11$1.42BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-05-11.revenue_estimatedRevenue · estimate — report date 2026-05-11$1.36BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-05-11.eps_actualEPS · reported — report date 2026-05-11$0.5000Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-05-11.eps_estimatedEPS · estimate — report date 2026-05-11$0.4200Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-02-26.revenue_actualRevenue · reported — report date 2026-02-26$1.36BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-02-26.revenue_estimatedRevenue · estimate — report date 2026-02-26$1.38BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-02-26.eps_actualEPS · reported — report date 2026-02-26$0.4300Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2026-02-26.eps_estimatedEPS · estimate — report date 2026-02-26$0.4800Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2025-11-19.revenue_actualRevenue · reported — report date 2025-11-19$1.34BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2025-11-19.revenue_estimatedRevenue · estimate — report date 2025-11-19$1.11BReport date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2025-11-19.eps_actualEPS · reported — report date 2025-11-19$0.3300Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
earn.history.depth.2025-11-19.eps_estimatedEPS · estimate — report date 2025-11-19$0.4500Report date · FMPFinancial Modeling Prep (FMP) earnings — Earnings-history note
fin.q_tableQuarterly income statement4 quarters through Q2 FY2026FMPFinancial Modeling Prep (FMP) · income statement (quarterly), as filed
fin.cash_investmentsCash and short-term investments$164.45MFMPFinancial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review.
fin.opcf_latestLatest-quarter operating cash flow$135.51MFMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate.
fin.long_term_investmentsLong-term investments (classification unverified)$0.00FMPFinancial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability.
fin.total_debtTotal debt$3.25BFMPFinancial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability.
fin.price_to_bookPrice to book value6.93×FMPFinancial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero.
fin.opcf.depth.2026-06-30.operating_cash_flow_mOperating cash flow — period end 2026-06-30$135.51MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2026-03-31.operating_cash_flow_mOperating cash flow — period end 2026-03-31$236.34MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2026-06-30.capex_mCapital expenditure (reported) — period end 2026-06-30−$26.53MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2026-03-31.capex_mCapital expenditure (reported) — period end 2026-03-31−$21.83MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2025-12-31.operating_cash_flow_mOperating cash flow — period end 2025-12-31−$3.39MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2025-12-31.capex_mCapital expenditure (reported) — period end 2025-12-31−$51.11MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2025-09-30.operating_cash_flow_mOperating cash flow — period end 2025-09-30$204.80MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
fin.opcf.depth.2025-09-30.capex_mCapital expenditure (reported) — period end 2025-09-30−$18.01MPeriod end · FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note
earn.pt_rangeAnalyst price target, low to high$48.00 – $62.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 26, 2026 · Coverage not supplied
earn.pt_consensusConsensus analyst price target$56.67FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 26, 2026 · Coverage not supplied
earn.pt_medianMedian analyst price target$60.00FMPFinancial Modeling Prep (FMP) · price-target consensus — Captured Oct 26, 2026 · Coverage not supplied
own.insidersInsider transactions via FMP59 transactions · 0 purchases, 58 sales, 1 other transactions · 5 identified insiders · of the newest 60 records, those within the last 180 days, newest dated Oct 21, 2026FMPFinancial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
own.institutions.depth.ownership_pctInstitutional ownership31.8%FMPFinancial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026
own.institutions.depth.ownership_pct_previous_quarterPrevious quarter · ownership29.8%FMPFinancial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026
own.institutions.depth.holdersReporting holders251FMPFinancial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026
own.institutions.depth.holders_previous_quarterPrevious quarter · holders226FMPFinancial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026
own.top_holders.depth.holder_0.sharesCohen & Steers, INC. — shares in provider snapshot8,343,381FMPFinancial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied.
own.top_holders.depth.holder_1.sharesFmr LLC — shares in provider snapshot6,207,375FMPFinancial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied.
own.top_holders.depth.holder_2.sharesBlackrock, INC. — shares in provider snapshot4,155,408FMPFinancial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied.
own.top_holders.depth.holder_3.sharesCrewe Advisors LLC — shares in provider snapshot3,307,188FMPFinancial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied.
own.top_holders.depth.holder_4.sharesAmerican Century Companies INC — shares in provider snapshot3,108,196FMPFinancial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied.

UNRECORDED — 2 facts from stored observations whose source was not recorded

UNRECORDED facts used on this page
Fact IDFactValue as shownAs ofTierSource
earn.historyReported versus estimated, recent quartersEPS beat 4 of 8UNRECORDEDStored earnings-history observation — Captured 2026-10-13 · Expired observation
fin.scoresDistress and quality screensAltman Z 2.31 · Piotroski F 7UNRECORDEDStored financial-scores observation — Captured 2026-10-24 · Expired observation

COMPUTED — 3 facts from our arithmetic, formula restated

COMPUTED facts used on this page
Fact IDFactValue as shownAs ofTierSource
fin.mcap_to_cashMarket value per dollar of cash and short-term investments46.82×—COMPUTEDComputed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $164.45M at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-26. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio.
earn.history.depth.2026-08-04.revenue_actual.comparisonLatest report · revenue vs estimateAbove estimateReport date · COMPUTEDComputed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($1.43B) with the recorded estimate ($1.41B) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns.
earn.history.depth.2026-08-04.eps_actual.comparisonLatest report · EPS vs estimateAbove estimateReport date · COMPUTEDComputed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.6300) with the recorded estimate ($0.5370) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns.

OURS — 2 facts from Stock Expert AI's own score and rank

OURS facts used on this page
Fact IDFactValue as shownAs ofTierSource
ours.moonshotMoonshotScore v290 of 100 · Exceptional · pillars 79 / 39 / 63 / 99 / 94OURSStock Expert AI MoonshotScore v2 engine
ours.moonshot_changeMoonshotScore movement90 (stored snapshot Oct 24, 2026) → 90 (current publication computed Oct 26, 2026) (0)OURSStock Expert AI current score publication and immutable score snapshots

Fact-family notes

  1. Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs: fin.q_table.depth.2026-06-30.revenue_k, fin.q_table.depth.2026-06-30.sga_k, fin.q_table.depth.2026-06-30.operating_result_k, fin.q_table.depth.2026-03-31.revenue_k, fin.q_table.depth.2026-03-31.sga_k, fin.q_table.depth.2026-03-31.operating_result_k, fin.q_table.depth.2025-12-31.revenue_k, fin.q_table.depth.2025-12-31.sga_k, fin.q_table.depth.2025-12-31.operating_result_k, fin.q_table.depth.2025-09-30.revenue_k, fin.q_table.depth.2025-09-30.sga_k, fin.q_table.depth.2025-09-30.operating_result_k.
  2. Earnings-history note. Source series as of 2026-08-04. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs: earn.history.depth.2026-08-04.revenue_actual, earn.history.depth.2026-08-04.revenue_estimated, earn.history.depth.2026-08-04.revenue_actual.comparison, earn.history.depth.2026-08-04.eps_actual.comparison, earn.history.depth.2026-08-04.eps_actual, earn.history.depth.2026-08-04.eps_estimated, earn.history.depth.2026-05-11.revenue_actual, earn.history.depth.2026-05-11.revenue_estimated, earn.history.depth.2026-05-11.eps_actual, earn.history.depth.2026-05-11.eps_estimated, earn.history.depth.2026-02-26.revenue_actual, earn.history.depth.2026-02-26.revenue_estimated, earn.history.depth.2026-02-26.eps_actual, earn.history.depth.2026-02-26.eps_estimated, earn.history.depth.2025-11-19.revenue_actual, earn.history.depth.2025-11-19.revenue_estimated, earn.history.depth.2025-11-19.eps_actual, earn.history.depth.2025-11-19.eps_estimated.
  3. Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs: fin.opcf.depth.2026-06-30.operating_cash_flow_m, fin.opcf.depth.2026-03-31.operating_cash_flow_m, fin.opcf.depth.2026-06-30.capex_m, fin.opcf.depth.2026-03-31.capex_m, fin.opcf.depth.2025-12-31.operating_cash_flow_m, fin.opcf.depth.2025-12-31.capex_m, fin.opcf.depth.2025-09-30.operating_cash_flow_m, fin.opcf.depth.2025-09-30.capex_m.
Published
Research standards
Methodology · Editorial policy · Corrections

Sources used for research written 2026-09-13

Historical evidence preserved with this analysis. Current figures are listed separately above.

EvidenceCaptured valueSource dateSource typeSource
Legal name
PACS Group, Inc.
2026-02-27OFFICIALSEC EDGAR — 10-K filed 2026-02-27
Business description
PACS Group, Inc. operates as a holding company, primarily focused on delivering post-acute healthcare services. This encompasses operating various facilities, providing skilled professionals, and offering essential ancillary support. The company further specializes in providing a spectrum of senior living options, encompassing dedicated senior care, assisted living, and independent living residences in select communities. Founded in 2013 by Jason Murray and Mark Hancock, its corporate headquarters are located in Farmington, Utah.
2026-09-13FMPFinancial Modeling Prep (FMP) company profile
Quarterly income statement (USD thousands)
Captured record · 8 entries
  • Quarter ended 2026-06-30 — EPS: $0.47 per share, SG&A: $114.31M, EPS basic: $0.48 per share, EPS basis: diluted, Revenue: $1.43B, EPS diluted: $0.47 per share, Net result: $76.37M, Gross profit: $338.46M, Operating result: $109.33M
  • Quarter ended 2026-03-31 — EPS: $0.5 per share, SG&A: $112.31M, EPS basic: $0.51 per share, EPS basis: diluted, Revenue: $1.42B, EPS diluted: $0.5 per share, Net result: $80.69M, Gross profit: $232.35M, Operating result: $120.03M
  • Quarter ended 2025-12-31 — EPS: $0.38 per share, SG&A: $113.49M, EPS basic: $0.38 per share, EPS basis: diluted, Revenue: $1.36B, EPS diluted: $0.38 per share, Net result: $59.70M, Gross profit: $223.56M, Operating result: $94.69M
  • Quarter ended 2025-09-30 — EPS: $0.32 per share, SG&A: $102.53M, EPS basic: $0.33 per share, EPS basis: diluted, Revenue: $1.34B, EPS diluted: $0.32 per share, Net result: $52.41M, Gross profit: $298.31M, Operating result: $86.27M
  • Quarter ended 2025-06-30 — EPS: $0.31 per share, SG&A: $100.33M, EPS basic: $0.33 per share, EPS basis: diluted, Revenue: $1.31B, EPS diluted: $0.31 per share, Net result: $50.96M, Gross profit: $288.36M, Operating result: $80.50M
  • Quarter ended 2025-03-31 — EPS: $0.17 per share, SG&A: $98.72M, EPS basic: $0.18 per share, EPS basis: diluted, Revenue: $1.28B, EPS diluted: $0.17 per share, Net result: $28.47M, Gross profit: $253.36M, Operating result: $48.14M
  • Quarter ended 2024-12-31 — EPS: $0.24 per share, SG&A: $89.64M, EPS basic: $0.24 per share, EPS basis: diluted, Revenue: $1.21B, EPS diluted: $0.24 per share, Net result: $37.20M, Gross profit: $174.54M, Operating result: $71.98M
  • Quarter ended 2024-09-30 — EPS: $0.1 per share, SG&A: $70.59M, EPS basic: $0.1 per share, EPS basis: diluted, Revenue: $1.03B, EPS diluted: $0.1 per share, Net result: $15.62M, Gross profit: $104.07M, Operating result: $22.96M
2026-06-30FMPFinancial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements
Operating cash flow by quarter (USD millions)
Captured record · 8 entries
  • Quarter ended 2026-06-30 — Capital expenditure: -$26.53M, Operating cash flow: $135.51M
  • Quarter ended 2026-03-31 — Capital expenditure: -$21.83M, Operating cash flow: $236.34M
  • Quarter ended 2025-12-31 — Capital expenditure: -$51.11M, Operating cash flow: -$3.39M
  • Quarter ended 2025-09-30 — Capital expenditure: -$18.01M, Operating cash flow: $204.80M
  • Quarter ended 2025-06-30 — Capital expenditure: -$18.57M, Operating cash flow: $52.57M
  • Quarter ended 2025-03-31 — Capital expenditure: -$17.72M, Operating cash flow: $150.24M
  • Quarter ended 2024-12-31 — Capital expenditure: -$83.17M, Operating cash flow: $64.59M
  • Quarter ended 2024-09-30 — Capital expenditure: -$65.89M, Operating cash flow: $209.23M
2026-06-30FMPFinancial Modeling Prep (FMP), from the company's 10-Q cash-flow statements
Cash, investments and debt
Total debt: $3.25B; Liquidity basis: cash and short-term investments; Total liabilities: $4.54B; Cash and short-term investments: $164.45M; Cash and investments: $164.50M; Long-term investments: $0; Long-term investments classification: unclassified

Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability.

2026-06-30FMPFinancial Modeling Prep (FMP), from the company's balance sheet
Sector / industry (provider taxonomy)
Healthcare / Medical - Care Facilities

The company's SEC filings classify it under SIC 8051 — Services-Skilled Nursing Care Facilities.

2026-09-13FMPFinancial Modeling Prep (FMP) company profile
Employees
Count: 47,455
2024-12-31FMPFinancial Modeling Prep (FMP) employee count, from the company's filing
Revenue by segment
Reportable Segment: $5.29B
2025-12-31FMPFinancial Modeling Prep (FMP) revenue segmentation, from the company's 10-K
Reported versus estimated, last 8 quarters
Captured record · 8 entries
  • Reported 2026-08-04 — EPS actual: $0.63 per share, EPS estimated: $0.537 per share, Revenue actual: $1.43B, Revenue estimated: $1.41B
  • Reported 2026-05-11 — EPS actual: $0.5 per share, EPS estimated: $0.42 per share, Revenue actual: $1.42B, Revenue estimated: $1.36B
  • Reported 2026-02-26 — EPS actual: $0.43 per share, EPS estimated: $0.48 per share, Revenue actual: $1.36B, Revenue estimated: $1.38B
  • Reported 2025-11-19 — EPS actual: $0.33 per share, EPS estimated: $0.45 per share, Revenue actual: $1.34B, Revenue estimated: $1.11B
  • Reported 2025-08-18 — EPS actual: $0.555 per share, EPS estimated: $0.3894 per share, Revenue actual: $1.31B, Revenue estimated: $1.13B
  • Reported 2025-05-19 — EPS actual: $0.42 per share, EPS estimated: $0.4239 per share, Revenue actual: $1.10B, Revenue estimated: $1.09B
  • Reported 2025-02-26 — EPS actual: $0.3911 per share, EPS estimated: $0.3958 per share, Revenue actual: $1.04B, Revenue estimated: $1.06B
  • Reported 2024-11-08 — EPS actual: $0.3535 per share, EPS estimated: $0.3434 per share, Revenue actual: $995.20M, Revenue estimated: $991.78M
2026-08-04FMPFinancial Modeling Prep (FMP) earnings
Management outlook — dated call excerpts
Captured record · 2 entries
  • Call of 2026-08-05 — Quote: As we look at the back half of the year, we expect to continue to perform at a high level, and therefore, we're increasing both our full year revenue and our adjusted EBITDA guidance., Speaker: Carey Hendrickson
  • Call of 2026-08-05 — Quote: I would say we do expect to receive them in the second half of the year, but we've not included any of that in our guidance., Speaker: Carey Hendrickson

Selected verbatim statements from the latest available call, dated by the transcript provider. Management expectations, not completed milestones or guarantees. Relative dates retain the speaker's wording.

2026-08-05OFFICIALCompany earnings call, transcript via Financial Modeling Prep (FMP)
Most recent periodic reports2026-08-04OFFICIALSEC EDGAR filer submissions
Annual revenue and net result (USD millions)
Captured record · 5 entries
  • FY2025 — R&D: $0, Revenue: $5.29B, Period end: 2025-12-31, Net result: $191.54M
  • FY2024 — R&D: $0, Revenue: $4.09B, Period end: 2024-12-31, Net result: $55.76M
  • FY2023 — R&D: $0, Revenue: $3.11B, Period end: 2023-12-31, Net result: $112.87M
  • FY2022 — R&D: $0, Revenue: $2.42B, Period end: 2022-12-31, Net result: $150.50M
  • FY2021 — R&D: $0, Revenue: $1.17B, Period end: 2021-12-31, Net result: $47.95M
2025-12-31FMPFinancial Modeling Prep (FMP), from the company's 10-K income statements
Cash and short-term investments over time (USD millions)
Captured record · 8 entries
  • 2026-06-30 — Amount: $164.50M, Cash basis: cash and short-term investments
  • 2026-03-31 — Amount: $248.00M, Cash basis: cash and short-term investments
  • 2025-12-31 — Amount: $197.00M, Cash basis: cash and short-term investments
  • 2025-09-30 — Amount: $355.70M, Cash basis: cash and short-term investments
  • 2025-06-30 — Amount: $294.20M, Cash basis: cash and short-term investments
  • 2025-03-31 — Amount: $287.50M, Cash basis: cash and short-term investments
  • 2024-12-31 — Amount: $157.70M, Cash basis: cash and short-term investments
  • 2024-09-30 — Amount: $49.50M, Cash basis: cash and short-term investments
2026-06-30FMPFinancial Modeling Prep (FMP), from the company's quarterly balance sheets
Trailing twelve-month ratio set
Quick ratio: 0.91; Current ratio: 0.91; Debt to equity: 2.93; Net margin: 4.8%; Gross margin: 19.7%; Operating margin: 7.4%; Return on assets: 4.8%; Return on equity: 27.2%

Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero.

2026-09-13FMPFinancial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm
Next earnings report
Date: 2026-11-09; EPS estimate: $0.573 per share; Revenue estimate: $1.46B

The date is our provider's estimate until the company confirms it.

2026-09-13FMPFinancial Modeling Prep (FMP) earnings calendar
Analyst revenue and earnings estimates (average)
Captured record · 4 entries
  • FY2025 — EPS average: $1.74 per share, Revenue average: $5.31B, Revenue low: $5.22B, Revenue high: $5.32B, Analysts (revenue): 3
  • FY2026 — EPS average: $2.37 per share, Revenue average: $5.83B, Revenue low: $5.73B, Revenue high: $6.00B, Analysts (revenue): 4
  • FY2027 — EPS average: $2.62 per share, Revenue average: $6.38B, Revenue low: $6.26B, Revenue high: $6.39B, Analysts (revenue): 4
  • FY2028 — EPS average: $2.84 per share, Revenue average: $6.94B, Revenue low: $6.60B, Revenue high: $7.31B, Analysts (revenue): 4
2026-09-13FMPFinancial Modeling Prep (FMP) analyst estimates
Cash against market value
As of: 2026-06-30; Cash basis: cash and short-term investments; Net cash: -$3.09B; Total debt: $3.25B; Cash and investments: $164.50M

Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. Cash is the latest reported cash and short-term investment balance; long-term investments are excluded. Market capitalization is the latest provider value.; The reported balance does not establish unrestricted availability or liquidation value.; The two are measured on different dates — the balance sheet is a quarter-end, the market cap is a recent close.; Debt is total debt as reported, including operating lease liabilities where the filer includes them.

2026-06-30COMPUTEDComputed from the balance sheet and the latest market capitalization
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.